Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2121630 | 1.00 | TSHR (0.40) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL21983652 | 0.95 | TSHR (0.43) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL2120183 | 0.93 | TSHR (0.40) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL15538517 | 0.93 | TSHR (0.42) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL2324973 | 0.87 | TSHR (0.44) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL21983938 | 0.87 | TSHR (0.39) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL11330708 | 0.81 | TSHR (0.47) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL11333895 | 0.81 | TSHR (0.47) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL11331956 | 0.81 | TSHR (0.47) | TSHRUSP2MAPTKDM4ETDP1 | |
| SCHEMBL2046218 | 0.81 | TSHR (0.47) | TSHRUSP2MAPTKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094190-A1 | ASYMMETRIC AND/OR LOW-SYMMETRIC FLUORINE-CONTAINING PHOSPHATE FOR NON-AQUEOUS ELECTROLYTE SOLUTION | TOSOH F-TECH, INC. (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094190-A1 | ASYMMETRIC AND/OR LOW-SYMMETRIC FLUORINE-CONTAINING PHOSPHATE FOR NON-AQUEOUS ELECTROLYTE SOLUTION | NAF1, AFF1, PHOSPHO1 | TSHR 1704/4885USP2 4191/4885MAPT 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.